zalcitabine has been researched along with caryophyllene in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aly, E; Khajah, MA; Masocha, W | 1 |
1 other study(ies) available for zalcitabine and caryophyllene
Article | Year |
---|---|
β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.
Topics: Animals; Brain; Disease Models, Animal; Female; Humans; Hyperalgesia; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Neuralgia; Polycyclic Sesquiterpenes; Receptor, Cannabinoid, CB2; Reverse Transcriptase Inhibitors; Skin; Zalcitabine | 2019 |